Cargando…
Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons
BACKGROUND: Brimonidine is a common drug for lowering ocular pressure and may directly protect retinal ganglion cells in glaucoma. The disease involves early loss of retinal ganglion cell transport to brain targets followed by axonal and somatic degeneration. We examined whether brimonidine preserve...
Autores principales: | Lambert, Wendi S, Ruiz, Lupe, Crish, Samuel D, Wheeler, Larry A, Calkins, David J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035592/ https://www.ncbi.nlm.nih.gov/pubmed/21232114 http://dx.doi.org/10.1186/1750-1326-6-4 |
Ejemplares similares
-
Brimonidine is Neuroprotective in Animal Paradigm of Retinal Ganglion Cell Damage
por: Conti, Federica, et al.
Publicado: (2021) -
Development and Degeneration of Retinal Ganglion Cell Axons in Xenopus tropicalis
por: Choi, Boyoon, et al.
Publicado: (2022) -
Retinal ganglion cell axonal compression by retinal vessels in light-induced retinal degeneration
por: García-Ayuso, Diego, et al.
Publicado: (2011) -
Axonal protection by brimonidine with modulation of p62 expression in TNF-induced optic nerve degeneration
por: Kitaoka, Yasushi, et al.
Publicado: (2015) -
Rescuing axons from degeneration does not affect retinal ganglion cell death
por: de Lima, S., et al.
Publicado: (2016)